Header Logo

Connection

Caleb Scheckel to Proto-Oncogene Proteins B-raf

This is a "connection" page, showing publications Caleb Scheckel has written about Proto-Oncogene Proteins B-raf.
Connection Strength

0.346
  1. Efficacy of BRAF-Inhibitor Therapy in BRAFV600E -Mutated Adult Langerhans Cell Histiocytosis. Oncologist. 2020 12; 25(12):1001-1004.
    View in: PubMed
    Score: 0.175
  2. Low-dose vemurafenib monotherapy in BRAFV600E -mutated Erdheim-Chester disease. Leuk Lymphoma. 2020 11; 61(11):2733-2737.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.